drugset / Trial / NCT04038099

Lessons on Urethral Lidocaine in Urodynamics

NCT04038099 ↗

Phase 4 Completed 63 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupDouble-blindDiagnostic

Summary

This trial will assess whether use of intraurethral 2% lidocaine jelly meaningfully impacts sensation during filling (i.e., a change of more than 25% of first sensation, first desire to void, strong desire to void, or maximum cystometric capacity) and determine whether the use of intraurethral 2% lidocaine jelly meaningfully impacts pain/discomfort, filling metrics, and voiding metrics.

Timeline

Start
2019-08-14
Primary completion
2021-08-18
Completion
2021-08-18

Publications

  • Results Hicks, C., Schaffer, J., Pruzynski, J., & Rahn, D. (2022). Impact of Intraurethral Lidocaine on Cystometric Parameters and Patient Discomfort: A Randomized Controlled Trial. Urologic Nursing, 42(5), 237-257. https://doi.org/10.7257/2168-4626.2022.42.5.237

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 % Other
Comparator Lidocaine Other / unclassified 5 ml Other